235 related articles for article (PubMed ID: 36293924)
21. Effects of cannabis on congenital limb anomalies in 14 European nations: A geospatiotemporal and causal inferential study.
Reece AS; Hulse GK
Environ Epigenet; 2022; 8(1):dvac016. PubMed ID: 35966826
[TBL] [Abstract][Full Text] [Related]
22. Congenital anomaly epidemiological correlates of Δ8THC across USA 2003-16: panel regression and causal inferential study.
Reece AS; Hulse GK
Environ Epigenet; 2022; 8(1):dvac012. PubMed ID: 35782486
[TBL] [Abstract][Full Text] [Related]
23. Clinical Epigenomic Explanation of the Epidemiology of Cannabinoid Genotoxicity Manifesting as Transgenerational Teratogenesis, Cancerogenesis and Aging Acceleration.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834053
[TBL] [Abstract][Full Text] [Related]
24. Broad Spectrum epidemiological contribution of cannabis and other substances to the teratological profile of northern New South Wales: geospatial and causal inference analysis.
Reece AS; Hulse GK
BMC Pharmacol Toxicol; 2020 Nov; 21(1):75. PubMed ID: 33183341
[TBL] [Abstract][Full Text] [Related]
25. Patterns of Cannabis- and Substance-Related Congenital General Anomalies in Europe: A Geospatiotemporal and Causal Inferential Study.
Reece AS; Hulse GK
Pediatr Rep; 2023 Feb; 15(1):69-118. PubMed ID: 36810339
[TBL] [Abstract][Full Text] [Related]
26. Multivariate classification of cannabis chemovars based on their terpene and cannabinoid profiles.
Birenboim M; Chalupowicz D; Maurer D; Barel S; Chen Y; Fallik E; Paz-Kagan T; Rapaport T; Sadeh A; Kengisbuch D; Shimshoni JA
Phytochemistry; 2022 Aug; 200():113215. PubMed ID: 35483556
[TBL] [Abstract][Full Text] [Related]
27. Cannabis Teratology Explains Current Patterns of Coloradan Congenital Defects: The Contribution of Increased Cannabinoid Exposure to Rising Teratological Trends.
Reece AS; Hulse GK
Clin Pediatr (Phila); 2019 Sep; 58(10):1085-1123. PubMed ID: 31288542
[TBL] [Abstract][Full Text] [Related]
28. Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development.
Reece AS; Hulse GK
Sci Rep; 2021 Jul; 11(1):13892. PubMed ID: 34230557
[TBL] [Abstract][Full Text] [Related]
29. Can cannabis kill? Characteristics of deaths following cannabis use in England (1998-2020).
Rock KL; Englund A; Morley S; Rice K; Copeland CS
J Psychopharmacol; 2022 Dec; 36(12):1362-1370. PubMed ID: 35946604
[TBL] [Abstract][Full Text] [Related]
30. Cannabis- and Substance-Related Carcinogenesis in Europe: A Lagged Causal Inferential Panel Regression Study.
Reece AS; Bennett K; Hulse GK
J Xenobiot; 2023 Jul; 13(3):323-385. PubMed ID: 37489337
[TBL] [Abstract][Full Text] [Related]
31. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure.
Lambros AM; Sagar KA; Dahlgren MK; Kosereisoglu D; El-Abboud C; Smith RT; Gruber SA
Sci Rep; 2023 Apr; 13(1):5869. PubMed ID: 37041309
[TBL] [Abstract][Full Text] [Related]
32. Letter to the editor on "Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017, parts 1-3".
Chen FY; Barnes M; Lewis EC
Arch Public Health; 2022 Jul; 80(1):172. PubMed ID: 35850921
[TBL] [Abstract][Full Text] [Related]
33. Geospatiotemporal and Causal Inferential Study of European Epidemiological Patterns of Cannabis- and Substance-Related Congenital Orofacial Anomalies.
Reece AS; Hulse GK
J Xenobiot; 2023 Feb; 13(1):42-74. PubMed ID: 36810431
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805384
[TBL] [Abstract][Full Text] [Related]
35. Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies.
De Aquino JP; Bahji A; Gómez O; Sofuoglu M
Drug Alcohol Depend; 2022 Dec; 241():109702. PubMed ID: 36434879
[TBL] [Abstract][Full Text] [Related]
36. Identification of cannabinoids in post-mortem blood samples from the province of New Brunswick before and after recreational cannabis legalization.
Jordan A; Sherazi A; Flewelling AJ; Northrup V; Naseemuddin A; Shea JL
Int J Drug Policy; 2022 May; 103():103629. PubMed ID: 35228057
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Five Commonly Analyzed Cannabinoids in Forensic Toxicology Casework from Orange County CA, USA, from 2016 to 2019.
Meneses VM; Mata DC
J Anal Toxicol; 2022 Apr; 46(4):449-456. PubMed ID: 33734396
[TBL] [Abstract][Full Text] [Related]
38. Associations between Prenatal and Postnatal Exposure to Cannabis with Cognition and Behavior at Age 5 Years: The Healthy Start Study.
Moore BF; Salmons KA; Hoyt AT; Swenson KS; Bates EA; Sauder KA; Shapiro ALB; Wilkening G; Kinney GL; Neophytou AM; Sempio C; Klawitter J; Christians U; Dabelea D
Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981794
[TBL] [Abstract][Full Text] [Related]
39. European epidemiological patterns of cannabis- and substance-related congenital cardiovascular anomalies: geospatiotemporal and causal inferential study.
Reece AS; Hulse GK
Environ Epigenet; 2022; 8(1):dvac015. PubMed ID: 35966825
[TBL] [Abstract][Full Text] [Related]
40. High Prevalence and Early Onsets: Legal and Illegal Substance Use in an Urban Cohort of Young Adults in Switzerland.
Quednow BB; Steinhoff A; Bechtiger L; Ribeaud D; Eisner M; Shanahan L
Eur Addict Res; 2022; 28(3):186-198. PubMed ID: 34864731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
